Skip to main content
George Diaz, MD, Medical Genetics, New York, NY

GeorgeAlfredDiazMDPhD

Medical Genetics New York, NY

Clinical Genetics

Professor, Division of Medical Genetics

Dr. Diaz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Diaz's full profile

Already have an account?

  • Office

    1 Gustave L. Levy Place
    Atran Building, 1-12
    New York, NY 10019
    Phone+1 212-241-6947
    Fax+1 212-860-3316

Education & Training

  • Icahn School of Medicine at Mount Sinai/Kravis Children's
    Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1994 - 1996
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1994
  • Cornell University
    Cornell UniversityB.A., Biology, 1981 - 1985

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1995 - 2024
  • American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2016
  • New York Top Doctors Castle Connolly, 2016
  • New York Super Doctors 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Glutamine and Hyperammonemic Crises in Patients with Urea Cycle Disorders  
    Lee B, Diaz GA, Rhead WR, et al, Mol Genet Metab, 1/1/2016
  • Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project  
    Linderman MD, Sanderson SC, Sukiel SA, et al, Eur J Hum Genet, 1/1/2016
  • Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate  
    Hook D, Diaz GA, Lee B, et al, Mol Genet Metab Rep, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Urinary phenylacetylglutamine (U-PAGN) concentration as an adherence biomarker for patients with urea cycle disorders (UCDs) treated with glycerol phenylbutyrate (GPB). 
    1/1/2015
  • Metabolic Emergencies 
    Englewood Hospital Medical Center, Englewood, NJ - 1/1/2015
  • Genetics Basics and Overview of New Technologies 
    Beth Israel Hospital, New York, NY - 1/1/2015
  • Join now to see all

Other

  • Thiamine-Responsive Megaloblastic Anemia Syndrome 
    Oishi K, Diaz GA, GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, Univer
    http://www.genetests.org
    1/1/2010

Press Mentions

  • iECURE Appoints George Diaz, M.D., Ph.D., as VP, Therapeutic Area Lead for Urea Cycle Disorders
    iECURE Appoints George Diaz, M.D., Ph.D., as VP, Therapeutic Area Lead for Urea Cycle DisordersApril 25th, 2022
  • National Organization for Rare Disorders Designates the Mount Sinai Hospital as a Center of Excellence
    National Organization for Rare Disorders Designates the Mount Sinai Hospital as a Center of ExcellenceNovember 4th, 2021
  • Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease
    Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic DiseaseJuly 14th, 2021
  • Join now to see all

Other Languages

  • Spanish

Industry Relationships

  • Vice President, Therapeutic Area Lead - UCD, iECURE2022 - Present